Cargando…
Lack of expression of ALK and CD30 in breast carcinoma by immunohistochemistry irrespective of tumor characteristics
CD30 is a member of the tumor necrosis factor family of cell surface receptors normally expressed in lymphocytes, as well as some lymphomas, but has been described in other malignancies. Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor that belongs to the insulin receptor superfamily,...
Autores principales: | Nassif, Samer, El-Zaatari, Ziad M., Attieh, Michel, Hijazi, Maya, Fakhreddin, Najla, Aridi, Tarek, Boulos, Fouad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709128/ https://www.ncbi.nlm.nih.gov/pubmed/31393373 http://dx.doi.org/10.1097/MD.0000000000016702 |
Ejemplares similares
-
Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area - a Prospective Analysis
por: Tfayli, Arafat, et al.
Publicado: (2017) -
Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the Literature
por: Fakhruddin, Najla, et al.
Publicado: (2017) -
Shortcomings of ultrasound-guided fine needle aspiration in the axillary management of women with breast cancer
por: Attieh, Michel, et al.
Publicado: (2019) -
Lymphoepithelioma-Like Carcinoma of the Breast: A Case Report Unveiling Several Clinical and Histopathological Challenges
por: Aridi, Tarek, et al.
Publicado: (2018) -
Plasma cells and lymphoid aggregates in sleeve gastrectomy specimens: Normal or gastritis?
por: Chakhachiro, Zaher, et al.
Publicado: (2020)